Definitive radiotherapy for uterine cervix cancer: long term results for patients treated in the period from 1998 till 2002 at the Institute of Oncology Ljubljana
Open Access
|Jul 2013References
- 1. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.1999;1137-43.
- 2. Keys HM, Bundy BN, Stehman FB, Mudersprach LI, Chafe WE, Suggs CL 3rd, et al. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma.1999;1154-61.
- 3. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.1999;1339-48.
- 4. Green JA, Kirwan JM, Tierney JF, Symonds P, Fresco L, Collingwood M, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.2001;358(9284): 781-6.
- 5. Vale C. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: A systematic review and meta-analysis of individual patient data from 18 randomized trials.2008;5802-12.
- 6. Gerbaulet A, Pötter R, Haie-Meder C. Cervix cancer. In: Gerbaulet A, Pötter R, Haie-Meder C, editors.. Brussels: ESTRO; 2002. p. 301-63.
- 7. Pötter R, Van Limbergen E, Wambersie A. Reporting in brachytherapy: dose and volume specification. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors.. Brussels: ESTRO; 2002. p. 155-215.
- 8. ICRU, International Commission of Radiation Units and Measurements. Dose and volume specification for reporting intracavitary therapy in gynaecology.. Bethesda, MD: ICRU; 1985.
- 9. Massey JB, Pointon RS, Wilkinson JM. The Manchester System and the BCRU recommendations for brachytherapy source specification1985;911-3.
- 10. Guedea F, Ellison T, Venselaar J, Borras JP, Hoskin P, Poetter R, et al. Overview of brachytherapy resources in Europe: a survey of patterns of care study for brachytherapy in Europe.2007;50-4.
- 11. Guedea F, Ellison T, Hoskin P, Hellebust TP, Didier Peiffert D, Londres B, et al. Patterns of care of brachytherapy in Europe: updated results.2010;514-20.
- 12. Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GECESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.2005;235-45.
- 13. Pötter R, Haie-Meder C, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.2006;67-77.
- 14. Wachter-Gerstner N, Wachter S, Reinstadler E, Fellner C, Knocke TH, Wambersie A, et al. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point.2003;269-76.
- 15. Pötter R, VanLimbergen E, Gerstner N, Wambersie A. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.2001;11-8.
- 16. Pötter R. Modern imaging in brachytherapy. In: Gerbaulet A, Pötter R, Mazeron JJ, Meertens H, Van Limbergen E, editors. The GEC ESTRO handbook of brachytherapy. Brussels: ESTRO; 2002. p. 123-51.
- 17. Barillot I, Horiot JC, Maingon P, Truc G, Chaplain G, Comte J, et al. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies.2000;189-200.
- 18. Perez CA, Grigsby PW, Lockett MA, Chao KS, Williamson J. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation.1999;855-66.
- 19. Kovalic JJ, Perez CA, Grigsby PW, Lockett MA. The effect of volume of disease in patients with carcinoma of the uterine cervix.1991;905-10.
- 20. Perez CA, Fox S, Lockett MA, Grigsby PW, Camel HM, Galakatos A, et al. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods.1991;885-98.
- 21. Roeske JC, Mundt AJ, Halpern H, Sweeney P, Sutton H, Powers C, et al. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: A dosimetric analysis.1997;351-8.
- 22. Chen SW, Liang JA, Yeh LS, Yang SN, Shiau AC, Lin FJ. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.2004;663-71.
- 23. Ogino I, Kitamura T, Okamoto N, Yamasita K, Aikawa Y, Okajima H, et al. Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix.1995;725-34.
- 24. Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, et al. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.2001;1123-35.
- 25. Kim HJ, Kim S, Ha SW, Wu HG. Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer?2008;327-32.
- 26. Petric P, Hudej R, Marolt-Mušič M. MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study.2009;163-9.
- 27. Petric P, Hudej R, Rogelj P, Blas M, Segedin B, Zobec Logar HB, Dimopoulos JCA. Comparison of 3D MRI with high sampling efficiency and 2D multiplanar MRI for contouring in cervix cancer brachytherapy.2012;242-51.
- 28. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).1995;1341-6.
- 29. LENT SOMA scales for all anatomic sites.1995;1049-91.
- 30. Baškovič M, Cerar O, Kaučič M, Kocijan A, Kovačič J, Kuhelj J, et al. [Guidelines for the treatment of the gynaecological malignancies]. [Slovenian]. Ljubljana: Zveza slovenskih društev za boj proti raku; 1992.
- 31. Baškovič M, Bebar S, Cerar O, Fras AP, Kragelj B, Robič V, et al. [Gynaecological malignancies. Guidelines for the treatment at the Institute of Oncology Ljubljana and Gynaecological Clinic of the University Medical Centre Ljubljana]. [Slovenian]. 2nd revisioned edition. Ljubljana: Zveza slovenskih društev za boj proti raku; 2001.
- 32. Stržinar V, Baškovič M, Bebar S, Cerar O, Fras AP, Koritnik K, et al. [Gynaecological malignancies. Guidelines for the treatment at the Institute of Oncology Ljubljana and Gynaecological Clinic of the University Medical Centre Ljubljana]. [Slovenian]. 3rd revisioned edition. Ljubljana: Zveza slovenskih društev za boj proti raku, 2002.
- 33. Perez Ca, Breaux S, Bedwinek JM, Madoc-Jones H, Camel HM, Purdy JA, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. II. Analysis of complications.1984;235-46.
- 34. Fletcher GH, Hamburger AD. Female pelvis. Squamous cel carcinoma of the uterine cervix. In: Fletcher GH, editor. Textbook of radiotherapy. 3rd edition. Philadelphia: Lea and Febiger; 1980. p. 720-89.
- 35. Pötter R, Knocke TH, Fellner C, Baldass M, Reinthaller A, Kucera H. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.2000;159-72.
- 36. Horiot JC, Pigneux J, Pourquier H. Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases.1988;605-11.
- 37. Pernot M, Hoffstetter S, Peiffert D, Carolus JM, Guillemin F, Verhaeghe JL, et al. Statistical study of a series of 672 cases of carcinoma of the uterine cervix. Results and complications according to age and modalities of treatment.1995;568-81.
- 38. Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998; 41: 307-17. Erratum in:1999;1093
- 39. Barillot I, Horiot JC, Pigneux J, Schraub S, Pourquier H, Daly N, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors.1997;969-78.
- 40. Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, et al. High-dose brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.2001;1123-35.
- 41. Ferrigno R, Campos de Oliveira Faria SL, Weltman E, Salvajoli JV, Segreto RA, Pastore A, et al. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables.2003;695-706.
- 42. Lorvidhaya V, Tonusin A, Changwiwit W, Chitapanarux I, Srisomboon J, Wanwilairat S, et al. High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients.2000;1185-91.
- 43. Dimopolus J, Schard G, Berger D, Lang S, Goldner G, Helbich T, et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer: potential of MRI on delineation of target, patho-anatomical structures and organs at risk.2006;1380-8.
- 44. Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Pötter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: Design, application, treatment planning, and dosimetric results.2006;624-30.
- 45. Erickson B, Grossheim L, Mai J. Imaging the nondisplaced rectosigmoid during HDR brachytherapy for cervical cancer can alter dose specification. [Abstract].2004;S9.
- 46. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU referencepoint estimates of radiation doses delivered to bladder and rectum during itracavitary radiotherapy for cervical cancer.2005;131-7.
- 47. Kirisits C, Pötter R, Lang S, Dimopoulos J, Wachter-Gerstner N, Georg D. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.2005;901-11.
- 48. Datta NR, Srivastava A, Maria Das KJ, Gupta A, Rastogi N. Comparative assessment of doses to tumor, rectum, and bladder as evaluated by orthogonal radiographs vs. computer enhanced computed tomography-based intracavitary brachytherapy in cervical cancer.2006;223-9.
- 49. Cheng JC, Peng LC, Chen YH, Huang DY, Wu JK, Jian JJ. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.2003;1010-8.
- 50. Morris M, Eifel PJ, Lu J, Grigsby P, Levenback C, Stevens RE, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.1999;1137-43.
- 51. Haie-Meder C, de Crevoisier R, Bruna A, Lhommé C, Pautier P, Morice P, et al. Concomitant chemoradiation in patients with cervix cancer.2005;1032-8.
- 52. Heinzelmann F, Henke G, von Grafenstein M, Weidner M, Paulsen F, Staebler A, et al. Adjuvant radiochemotherapy in patients with locally advanced highrisk cervical cancer.2012;568-75.
- 53. Kim JY, Kim JY, Kim JH, Yoon MS, Kim J, Kim YS. Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases.2012;741-7.
- 54. Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.1995;1275-88.
Language: English
Page range: 280 - 288
Published on: Jul 30, 2013
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2013 Helena Barbara Zobec Logar, Barbara Segedin, Robert Hudej, Primoz Petric, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.